David Lebwohl, EVP, Chief Medical Officer: Intellia Therapeutics NTLA Sell · Filed 24/01/05

Trade details

Type: Insider sale
Amount: $172,134.78
Shares · price: 5,843 sh · $29.46 a share
Held after: 54,372 sh
Stock: Intellia Therapeutics NTLA
Person: David LebwohlEVP, Chief Medical Officer
Trade date: 24/01/03
Filed: 24/01/05
Days to filing: 2 days

Sold 9.7% of holdings

Share of holding sold: 9.7%

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/04~24/02/02

David Lebwohl's recent trades

David LebwohlEVP, Chief Medical Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$109.6K
11,903 sh
$109.6K
Filed 01/07
Traded 01/05
David LebwohlEVP, Chief Medical Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$116.4K
9,557 sh
$116.4K
Filed 25/01/07
Traded 25/01/03
David LebwohlEVP, Chief Medical Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$95.8K
2,574 sh
$95.8K
Filed 23/01/06
Traded 23/01/04